{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T11:45:52Z","timestamp":1793015152623,"version":"4.5.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["K24AI134990"],"award-info":[{"award-number":["K24AI134990"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI075045"],"award-info":[{"award-number":["R01AI075045"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U19AI089674"],"award-info":[{"award-number":["U19AI089674"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI117001"],"award-info":[{"award-number":["R01AI117001"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI189911-01"],"award-info":[{"award-number":["R01AI189911-01"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004167","name":"Medicines for Malaria Venture","doi-asserted-by":"publisher","award":["RD\/15\/0001"],"award-info":[{"award-number":["RD\/15\/0001"]}],"id":[{"id":"10.13039\/501100004167","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-035751"],"award-info":[{"award-number":["INV-035751"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1038\/s41591-026-04590-5","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T09:03:28Z","timestamp":1786957408000},"page":"3192-3202","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Emergence and spread of Plasmodium falciparum PX1 polymorphisms associated with decreased susceptibility to antimalarials in Uganda"],"prefix":"10.1038","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7406-9508","authenticated-orcid":false,"given":"Karamoko","family":"Niar\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4301-8764","authenticated-orcid":false,"given":"Bersabeh","family":"Tafesse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayland","family":"Treat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob M.","family":"Sadler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Okitwi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Orena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0489-4692","authenticated-orcid":false,"given":"Victor","family":"Asua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oriana","family":"Kreutzfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Legac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3592-1382","authenticated-orcid":false,"given":"Jacob","family":"Marglous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel L.","family":"Nsobya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adoke","family":"Yeka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dave","family":"Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"Ferdig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angana","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7953-7622","authenticated-orcid":false,"given":"Philip J.","family":"Rosenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0591-0850","authenticated-orcid":false,"given":"Jonathan J.","family":"Juliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6899-8204","authenticated-orcid":false,"given":"Jeffrey A.","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9984-8030","authenticated-orcid":false,"given":"Melissa D.","family":"Conrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,17]]},"reference":[{"key":"4590_CR1","unstructured":"Global Malaria Programme. World malaria report 2025 (World Health Organization, 2025); https:\/\/www.who.int\/teams\/global-malaria-programme\/reports\/world-malaria-report-2025"},{"key":"4590_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-021-06018-6","volume":"21","author":"W Shibeshi","year":"2021","unstructured":"Shibeshi, W., Alemkere, G., Mulu, A. & Engidawork, E. Efficacy and safety of artemisinin-based combination therapies for the treatment of uncomplicated malaria in pediatrics: a systematic review and meta-analysis. BMC Infect. Dis. 21, 326 (2021).","journal-title":"BMC Infect. Dis."},{"issue":"Suppl. 1","key":"4590_CR3","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1186\/1475-2875-8-S1-S5","volume":"8","author":"M Makanga","year":"2009","unstructured":"Makanga, M. & Krudsood, S. The clinical efficacy of artemether\/lumefantrine (Coartem\u00ae). Malar. J. 8 (Suppl. 1), S5 (2009).","journal-title":"Malar. J."},{"key":"4590_CR4","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S0163-7258(01)00140-1","volume":"90","author":"GA Balint","year":"2001","unstructured":"Balint, G. A. Artemisinin and its derivatives: an important new class of antimalarial agents. Pharmacol. Ther. 90, 261\u2013265 (2001).","journal-title":"Pharmacol. Ther."},{"key":"4590_CR5","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1056\/NEJMoa0808859","volume":"361","author":"AM Dondorp","year":"2009","unstructured":"Dondorp, A. M. et al. Artemisinin resistance in Plasmodium falciparum malaria. N. Engl. J. Med. 361, 455\u2013467 (2009).","journal-title":"N. Engl. J. Med."},{"key":"4590_CR6","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/S1473-3099(13)70252-4","volume":"13","author":"B Witkowski","year":"2013","unstructured":"Witkowski, B. et al. Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: In-vitro and ex-vivo drug-response studies. Lancet Infect. Dis. 13, 1043\u20131049 (2013).","journal-title":"Lancet Infect. Dis."},{"key":"4590_CR7","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S1473-3099(15)00487-9","volume":"16","author":"C Amaratunga","year":"2016","unstructured":"Amaratunga, C. et al. Dihydroartemisinin\u2013piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study. Lancet Infect. Dis. 16, 357\u2013365 (2016).","journal-title":"Lancet Infect. Dis."},{"key":"4590_CR8","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1093\/cid\/ciw388","volume":"63","author":"AP Phyo","year":"2016","unstructured":"Phyo, A. P. et al. Declining efficacy of artemisinin combination therapy against P. falciparum malaria on the Thai\u2013Myanmar border (2003\u20132013): the role of parasite genetic factors. Clin. Infect. Dis. 63, 784\u2013791 (2016).","journal-title":"Clin. Infect. Dis."},{"key":"4590_CR9","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1126\/science.1260403","volume":"347","author":"S Mok","year":"2015","unstructured":"Mok, S. et al. Population transcriptomics of human malaria parasites reveals the mechanism of artemisinin resistance. Science 347, 431\u2013435 (2015).","journal-title":"Science"},{"key":"4590_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006930","volume":"14","author":"F Rocamora","year":"2018","unstructured":"Rocamora, F. et al. Oxidative stress and protein damage responses mediate artemisinin resistance in malaria parasites. PLoS Pathog. 14, e1006930 (2018).","journal-title":"PLoS Pathog."},{"key":"4590_CR11","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1038\/s42003-024-07178-2","volume":"7","author":"A Rahman","year":"2024","unstructured":"Rahman, A. et al. Artemisinin-resistant Plasmodium falciparum Kelch13 mutant proteins display reduced heme-binding affinity and decreased artemisinin activation. Commun. Biol. 7, 1499 (2024).","journal-title":"Commun. Biol."},{"key":"4590_CR12","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1126\/science.aax4735","volume":"367","author":"J Birnbaum","year":"2020","unstructured":"Birnbaum, J. et al. A Kelch13-defined endocytosis pathway mediates artemisinin resistance in malaria parasites. Science 367, 51\u201359 (2020).","journal-title":"Science"},{"key":"4590_CR13","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/s41579-024-01008-2","volume":"22","author":"PJ Rosenthal","year":"2024","unstructured":"Rosenthal, P. J., Asua, V. & Conrad, M. D. Emergence, transmission dynamics and mechanisms of artemisinin partial resistance in malaria parasites in Africa. Nat. Rev. Microbiol. 22, 373\u2013384 (2024).","journal-title":"Nat. Rev. Microbiol."},{"key":"4590_CR14","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1056\/NEJMoa2211803","volume":"389","author":"MD Conrad","year":"2023","unstructured":"Conrad, M. D. et al. Evolution of partial resistance to artemisinins in malaria parasites in Uganda. N. Engl. J. Med. 389, 722\u2013732 (2023).","journal-title":"N. Engl. J. Med."},{"key":"4590_CR15","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1038\/s41591-020-1005-2","volume":"26","author":"A Uwimana","year":"2020","unstructured":"Uwimana, A. et al. Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda. Nat. Med. 26, 1602\u20131608 (2020).","journal-title":"Nat. Med."},{"key":"4590_CR16","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1093\/infdis\/jiae475","volume":"231","author":"N Wernsman Young","year":"2025","unstructured":"Wernsman Young, N. et al. High frequency of artemisinin partial resistance mutations in the great lakes region revealed through rapid pooled deep sequencing. J. Infect. Dis. 231, 269\u2013280 (2025).","journal-title":"J. Infect. Dis."},{"key":"4590_CR17","doi-asserted-by":"publisher","first-page":"100920","DOI":"10.1016\/S2666-5247(24)00160-5","volume":"5","author":"JJ Juliano","year":"2024","unstructured":"Juliano, J. J. et al. Prevalence of mutations associated with artemisinin partial resistance and sulfadoxine-pyrimethamine resistance in 13 regions in Tanzania in 2021: a cross-sectional survey. Lancet Microbe 5, 100920 (2024).","journal-title":"Lancet Microbe"},{"key":"4590_CR18","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1056\/NEJMoa2210956","volume":"389","author":"S Mihreteab","year":"2023","unstructured":"Mihreteab, S. et al. Increasing prevalence of artemisinin-resistant HRP2-negative malaria in Eritrea. N. Engl. J. Med. 389, 1191\u20131202 (2023).","journal-title":"N. Engl. J. Med."},{"key":"4590_CR19","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1038\/s41564-023-01461-4","volume":"8","author":"AA Fola","year":"2023","unstructured":"Fola, A. A. et al. Plasmodium falciparum resistant to artemisinin and diagnostics have emerged in Ethiopia. Nat. Microbiol. 8, 1911\u20131919 (2023).","journal-title":"Nat. Microbiol."},{"key":"4590_CR20","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/S1473-3099(24)00362-1","volume":"24","author":"DS Ishengoma","year":"2024","unstructured":"Ishengoma, D. S. et al. Evidence of artemisinin partial resistance in northwestern Tanzania: clinical and molecular markers of resistance. Lancet Infect. Dis. 24, 1225\u20131233 (2024).","journal-title":"Lancet Infect. Dis."},{"key":"4590_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33873-x","volume":"13","author":"PK Tumwebaze","year":"2022","unstructured":"Tumwebaze, P. K. et al. Decreased susceptibility of Plasmodium falciparum to both dihydroartemisinin and lumefantrine in northern Uganda. Nat. Commun. 13, 6353 (2022).","journal-title":"Nat. Commun."},{"key":"4590_CR22","doi-asserted-by":"publisher","first-page":"7353","DOI":"10.1038\/s41467-025-62810-x","volume":"16","author":"M Okitwi","year":"2025","unstructured":"Okitwi, M. et al. Changes in susceptibility of Plasmodium falciparum to antimalarial drugs in Uganda over time: 2019\u20132024. Nat. Commun. 16, 7353 (2025).","journal-title":"Nat. Commun."},{"key":"4590_CR23","doi-asserted-by":"publisher","first-page":"833","DOI":"10.4269\/ajtmh.14-0031","volume":"91","author":"M Venkatesan","year":"2014","unstructured":"Venkatesan, M. et al. Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether\u2013lumefantrine and artesunate\u2013amodiaquine. Am. J. Trop. Med. Hyg. 91, 833\u2013843 (2014).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"4590_CR24","doi-asserted-by":"publisher","first-page":"e1119","DOI":"10.1093\/infdis\/jiaf155","volume":"231","author":"C Fan\u00e7ony","year":"2025","unstructured":"Fan\u00e7ony, C. et al. Artemether\u2013lumefantrine treatment selects Plasmodium falciparum multidrug resistance 1 (pfmdr1) increased copy number among African malaria infections. J. Infect. Dis. 231, e1119\u2013e1128 (2025).","journal-title":"J. Infect. Dis."},{"key":"4590_CR25","doi-asserted-by":"publisher","first-page":"e441","DOI":"10.1016\/S2666-5247(21)00085-9","volume":"2","author":"PK Tumwebaze","year":"2021","unstructured":"Tumwebaze, P. K. et al. Drug susceptibility of Plasmodium falciparum in eastern Uganda: a longitudinal phenotypic and genotypic study. Lancet Microbe 2, e441\u2013e449 (2021).","journal-title":"Lancet Microbe"},{"key":"4590_CR26","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.4269\/ajtmh.2010.10-0339","volume":"83","author":"M Mungthin","year":"2010","unstructured":"Mungthin, M. et al. Association between the pfmdr1 gene and in vitro artemether and lumefantrine sensitivity in Thai isolates of Plasmodium falciparum. Am. J. Trop. Med. Hyg. 83, 1005\u20131009 (2010).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"4590_CR27","doi-asserted-by":"publisher","first-page":"915656","DOI":"10.3389\/fcimb.2022.915656","volume":"12","author":"R Kubota","year":"2022","unstructured":"Kubota, R., Ishino, T., Iwanaga, S. & Shinzawa, N. Evaluation of the effect of gene duplication by genome editing on drug resistance in Plasmodium falciparum. Front. Cell. Infect. Microbiol. 12, 915656 (2022).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"4590_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-025-05248-2","volume":"24","author":"VR Laird","year":"2025","unstructured":"Laird, V. R. et al. Plasmodium falciparum multidrug resistance 1 gene polymorphisms associated with outcomes after anti-malarial treatment. Malar. J. 24, 186 (2025).","journal-title":"Malar. J."},{"key":"4590_CR29","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1086\/503423","volume":"42","author":"RN Price","year":"2006","unstructured":"Price, R. N. et al. Molecular and pharmacological determinants of the therapeutic response to artemether\u2013lumefantrine in multidrug-resistant Plasmodium falciparum malaria. Clin. Infect. Dis. 42, 1570\u20131577 (2006).","journal-title":"Clin. Infect. Dis."},{"key":"4590_CR30","doi-asserted-by":"crossref","unstructured":"Rasmussen, S. A. et al. Changing antimalarial drug sensitivities in Uganda. Antimicrob. Agents Chemother. 61, e01516-17 (2017).","DOI":"10.1128\/AAC.01516-17"},{"key":"4590_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-021-04021-5","volume":"20","author":"C Ebong","year":"2021","unstructured":"Ebong, C. et al. Efficacy and safety of artemether\u2013lumefantrine and dihydroartemisinin\u2013piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria and prevalence of molecular markers associated with artemisinin and partner drug resistance in Uganda. Malar. J. 20, 484 (2021).","journal-title":"Malar. J."},{"key":"4590_CR32","doi-asserted-by":"publisher","unstructured":"Kamya, M. R. et al. Efficacies of artemether\u2013lumefantrine, artesunate\u2013amodiaquine, dihydroartemisininpiperaquine and artesunate\u2013pyronaridine for the treatment of uncomplicated Plasmodium falciparum malaria in children in Uganda: a randomized, open-label phase IV clinical trial. Social Science Research Network https:\/\/doi.org\/10.2139\/ssrn.5226564 (2025).","DOI":"10.2139\/ssrn.5226564"},{"key":"4590_CR33","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01659-23","volume":"68","author":"P Awor","year":"2024","unstructured":"Awor, P. et al. Indigenous emergence and spread of kelch13 C469Y artemisinin-resistant Plasmodium falciparum in Uganda. Antimicrob. Agents Chemother. 68, e0165923 (2024).","journal-title":"Antimicrob. Agents Chemother."},{"key":"4590_CR34","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1093\/infdis\/jiaa687","volume":"223","author":"V Asua","year":"2021","unstructured":"Asua, V. et al. Changing prevalence of potential mediators of aminoquinoline, antifolate, and artemisinin resistance across Uganda. J. Infect. Dis. 223, 985\u2013994 (2021).","journal-title":"J. Infect. Dis."},{"key":"4590_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-023-04632-0","volume":"22","author":"K Niar\u00e9","year":"2023","unstructured":"Niar\u00e9, K., Greenhouse, B. & Bailey, J. A. An optimized GATK4 pipeline for Plasmodium falciparum whole genome sequencing variant calling and analysis. Malar. J. 22, 207 (2023).","journal-title":"Malar. J."},{"key":"4590_CR36","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1038\/s41564-023-01377-z","volume":"8","author":"A Amambua-Ngwa","year":"2023","unstructured":"Amambua-Ngwa, A. et al. Chloroquine resistance evolution in Plasmodium falciparum is mediated by the putative amino acid transporter AAT1. Nat. Microbiol. 8, 1213\u20131226 (2023).","journal-title":"Nat. Microbiol."},{"key":"4590_CR37","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.03239-21","volume":"13","author":"A Mukherjee","year":"2022","unstructured":"Mukherjee, A. et al. A phosphoinositide-binding protein acts in the trafficking pathway of hemoglobin in the malaria parasite Plasmodium falciparum. mBio 13, e0323921 (2022).","journal-title":"mBio"},{"key":"4590_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07588-x","volume":"9","author":"L Zhu","year":"2018","unstructured":"Zhu, L. et al. The origins of malaria artemisinin resistance defined by a genetic and transcriptomic background. Nat. Commun. 9, 5158 (2018).","journal-title":"Nat. Commun."},{"key":"4590_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-016-1634-6","volume":"15","author":"M Ravenhall","year":"2016","unstructured":"Ravenhall, M. et al. Characterizing the impact of sustained sulfadoxine\/pyrimethamine use upon the Plasmodium falciparum population in Malawi. Malar. J. 15, 575 (2016).","journal-title":"Malar. J."},{"key":"4590_CR40","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1093\/infdis\/jiu349","volume":"210","author":"H Ocholla","year":"2014","unstructured":"Ocholla, H. et al. Whole-genome scans provide evidence of adaptive evolution in Malawian Plasmodium falciparum isolates. J. Infect. Dis. 210, 1991\u20132000 (2014).","journal-title":"J. Infect. Dis."},{"key":"4590_CR41","doi-asserted-by":"crossref","unstructured":"Hathaway, N. J. et al. Interchromosomal segmental duplication drives translocation and loss of P. falciparum histidine-rich protein 3. eLife 13, RP95334.","DOI":"10.7554\/eLife.93534.3"},{"key":"4590_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-51701-2","volume":"15","author":"WK Tang","year":"2024","unstructured":"Tang, W. K. et al. Multistage protective anti-CelTOS monoclonal antibodies with cross-species sterile protection against malaria. Nat. Commun. 15, 7487 (2024).","journal-title":"Nat. Commun."},{"key":"4590_CR43","doi-asserted-by":"publisher","first-page":"msad082","DOI":"10.1093\/molbev\/msad082","volume":"40","author":"MJM Lefebvre","year":"2023","unstructured":"Lefebvre, M. J. M. et al. Population genomic evidence of adaptive response during the invasion history of Plasmodium falciparum in the Americas. Mol. Biol. Evol. 40, msad082 (2023).","journal-title":"Mol. Biol. Evol."},{"key":"4590_CR44","doi-asserted-by":"publisher","first-page":"e1009576","DOI":"10.1371\/journal.pgen.1009576","volume":"17","author":"Z Shah","year":"2021","unstructured":"Shah, Z. et al. Whole-genome analysis of Malawian Plasmodium falciparum isolates identifies possible targets of allele-specific immunity to clinical malaria. PLoS Genet. 17, e1009576 (2021).","journal-title":"PLoS Genet."},{"key":"4590_CR45","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1093\/molbev\/msu106","volume":"31","author":"VA Mobegi","year":"2014","unstructured":"Mobegi, V. A. et al. Genome-wide analysis of selection on the malaria parasite Plasmodium falciparum in West African populations of differing infection endemicity. Mol. Biol. Evol. 31, 1490\u20131499 (2014).","journal-title":"Mol. Biol. Evol."},{"key":"4590_CR46","doi-asserted-by":"publisher","first-page":"42","DOI":"10.12688\/wellcomeopenres.16168.1","volume":"6","author":"MalariaGEN","year":"2021","unstructured":"MalariaGEN et al. An open dataset of Plasmodium falciparum genome variation in 7,000 worldwide samples. Wellcome Open Res. 6, 42 (2021).","journal-title":"Wellcome Open Res."},{"key":"4590_CR47","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1093\/cid\/ciad724","volume":"78","author":"DA van Schalkwyk","year":"2024","unstructured":"van Schalkwyk, D. A. et al. Treatment failure in a UK malaria patient harboring genetically variant Plasmodium falciparum from Uganda with reduced in vitro susceptibility to artemisinin and lumefantrine. Clin. Infect. Dis. 78, 445\u2013452 (2024).","journal-title":"Clin. Infect. Dis."},{"key":"4590_CR48","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02382-16","volume":"61","author":"CJ Sutherland","year":"2017","unstructured":"Sutherland, C. J. et al. Pfk13-independent treatment failure in four imported cases of Plasmodium falciparum malaria treated with artemether\u2013lumefantrine in the United Kingdom. Antimicrob. Agents Chemother. 61, e02382 (2017).","journal-title":"Antimicrob. Agents Chemother."},{"key":"4590_CR49","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/taaf013","volume":"32","author":"R Oliveira","year":"2025","unstructured":"Oliveira, R. et al. Artemether\u2013lumefantrine resistant falciparum malaria imported from Uganda. J. Travel Med. 32, taaf013 (2025).","journal-title":"J. Travel Med."},{"key":"4590_CR50","doi-asserted-by":"publisher","first-page":"e1007279","DOI":"10.1371\/journal.pgen.1007279","volume":"14","author":"L Henden","year":"2018","unstructured":"Henden, L., Lee, S., Mueller, I., Barry, A. & Bahlo, M. Identity-by-descent analyses for measuring population dynamics and selection in recombining pathogens. PLoS Genet. 14, e1007279 (2018).","journal-title":"PLoS Genet."},{"key":"4590_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-11-174","volume":"11","author":"E Espi\u00e9","year":"2012","unstructured":"Espi\u00e9, E. et al. Efficacy of fixed-dose combination artesunate\u2013amodiaquine versus artemether\u2013lumefantrine for uncomplicated childhood Plasmodium falciparum malaria in Democratic Republic of Congo: a randomized non-inferiority trial. Malar. J. 11, 174 (2012).","journal-title":"Malar. J."},{"key":"4590_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-015-0732-1","volume":"14","author":"G Ferrari","year":"2015","unstructured":"Ferrari, G. et al. An operational comparative study of quinine and artesunate for the treatment of severe malaria in hospitals and health centres in the Democratic Republic of Congo: the MATIAS study. Malar. J. 14, 226 (2015).","journal-title":"Malar. J."},{"key":"4590_CR53","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01818-18","volume":"63","author":"V Asua","year":"2019","unstructured":"Asua, V. et al. Changing molecular markers of antimalarial drug sensitivity across Uganda. Antimicrob. Agents Chemother. 63, e01818-18 (2019).","journal-title":"Antimicrob. Agents Chemother."},{"key":"4590_CR54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0020190","volume":"2","author":"A Yeka","year":"2005","unstructured":"Yeka, A. et al. Artemisinin versus nonartemisinin combination therapy for uncomplicated malaria: randomized clinical trials from four sites in Uganda. PLoS Med. 2, e190 (2005).","journal-title":"PLoS Med."},{"key":"4590_CR55","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1086\/647946","volume":"49","author":"E Arinaitwe","year":"2009","unstructured":"Arinaitwe, E. et al. Artemether\u2013lumefantrine versus dihydroartemisinin\u2013piperaquine for falciparum malaria: a longitudinal, randomized trial in young Ugandan children. Clin. Infect. Dis. 49, 1629\u20131637 (2009).","journal-title":"Clin. Infect. Dis."},{"key":"4590_CR56","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1093\/cid\/ciu353","volume":"59","author":"H Wanzira","year":"2014","unstructured":"Wanzira, H. et al. Longitudinal outcomes in a cohort of Ugandan children randomized to artemether\u2013lumefantrine versus dihydroartemisinin\u2013piperaquine for the treatment of malaria. Clin. Infect. Dis. 59, 509\u2013516 (2014).","journal-title":"Clin. Infect. Dis."},{"key":"4590_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-016-1641-7","volume":"15","author":"SO Oyola","year":"2016","unstructured":"Oyola, S. O. et al. Whole genome sequencing of Plasmodium falciparum from dried blood spots using selective whole genome amplification. Malar. J. 15, 597 (2016).","journal-title":"Malar. J."},{"key":"4590_CR58","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1101\/gr.203711.115","volume":"26","author":"A Miles","year":"2016","unstructured":"Miles, A. et al. Indels, structural variation, and recombination drive genomic diversity in Plasmodium falciparum. Genome Res. 26, 1288\u20131299 (2016).","journal-title":"Genome Res."},{"key":"4590_CR59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1005348","volume":"13","author":"H-H Chang","year":"2017","unstructured":"Chang, H.-H. et al. THE REAL McCOIL: a method for the concurrent estimation of the complexity of infection and SNP allele frequency for malaria parasites. PLoS Comput. Biol. 13, e1005348 (2017).","journal-title":"PLoS Comput. Biol."},{"key":"4590_CR60","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1093\/bioinformatics\/bts115","volume":"28","author":"M Gautier","year":"2012","unstructured":"Gautier, M. & Vitalis, R. rehh: an R package to detect footprints of selection in genome-wide SNP data from haplotype structure. Bioinformatics 28, 1176\u20131177 (2012).","journal-title":"Bioinformatics"},{"key":"4590_CR61","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1093\/bioinformatics\/btx011","volume":"33","author":"DE Cook","year":"2017","unstructured":"Cook, D. E. & Andersen, E. C. VCF-kit: assorted utilities for the variant call format. Bioinformatics 33, 1581\u20131582 (2017).","journal-title":"Bioinformatics"},{"key":"4590_CR62","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1101\/gr.6386707","volume":"17","author":"A Auton","year":"2007","unstructured":"Auton, A. & McVean, G. Recombination rate estimation in the presence of hotspots. Genome Res. 17, 1219\u20131227 (2007).","journal-title":"Genome Res."},{"key":"4590_CR63","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1126\/science.1092500","volume":"304","author":"GAT McVean","year":"2004","unstructured":"McVean, G. A. T. et al. The fine-scale structure of recombination rate variation in the human genome. Science 304, 581\u2013584 (2004).","journal-title":"Science"},{"key":"4590_CR64","doi-asserted-by":"publisher","first-page":"1526049","DOI":"10.3389\/fgene.2025.1526049","volume":"16","author":"K Niar\u00e9","year":"2025","unstructured":"Niar\u00e9, K. et al. Highly multiplexed molecular inversion probe panel in Plasmodium falciparum targeting common SNPs approximates whole-genome sequencing assessments for selection and relatedness. Front. Genet. 16, 1526049 (2025).","journal-title":"Front. Genet."},{"key":"4590_CR65","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-018-2349-7","volume":"17","author":"SF Schaffner","year":"2018","unstructured":"Schaffner, S. F., Taylor, A. R., Wong, W., Wirth, D. F. & Neafsey, D. E. hmmIBD: software to infer pairwise identity by descent between haploid genotypes. Malar. J. 17, 196 (2018).","journal-title":"Malar. J."},{"key":"4590_CR66","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1086\/519795","volume":"81","author":"S Purcell","year":"2007","unstructured":"Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559\u2013575 (2007).","journal-title":"Am. J. Hum. Genet."},{"key":"4590_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15779-8","volume":"11","author":"R Verity","year":"2020","unstructured":"Verity, R. et al. The impact of antimalarial resistance on the genetic structure of Plasmodium falciparum in the DRC. Nat. Commun. 11, 2107 (2020).","journal-title":"Nat. Commun."},{"key":"4590_CR68","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1093\/infdis\/jiy223","volume":"218","author":"O Aydemir","year":"2018","unstructured":"Aydemir, O. et al. Drug-resistance and population structure of Plasmodium falciparum across the Democratic Republic of Congo using high-throughput molecular inversion probes. J. Infect. Dis. 218, 946\u2013955 (2018).","journal-title":"J. Infect. Dis."},{"key":"4590_CR69","doi-asserted-by":"crossref","unstructured":"Meier-Scherling, C. P. G. et al. Selection of Plasmodium falciparum kelch13 mutations in Uganda in comparison with southeast Asia: a modelling study. Lancet Microbe 6, 101027 (2025).","DOI":"10.1016\/j.lanmic.2024.101027"},{"key":"4590_CR70","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/j.2041-210x.2012.00261.x","volume":"4","author":"S Nakagawa","year":"2013","unstructured":"Nakagawa, S. & Schielzeth, H. A general and simple method for obtaining R2 from generalized linear mixed-effects models. Methods Ecol. Evol. 4, 133\u2013142 (2013).","journal-title":"Methods Ecol. Evol."},{"key":"4590_CR71","doi-asserted-by":"publisher","unstructured":"Niare, K. Karaniare\/PfWGS-DRscanner: genome-wide scans for locus association with antimalarial drug responses in Plasmodium falciparum (version v1.0.0) [computer software]. Zenodo https:\/\/doi.org\/10.5281\/zenodo.21283869 (2026).","DOI":"10.5281\/zenodo.21283869"}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41591-026-04590-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-026-04590-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-026-04590-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T14:03:06Z","timestamp":1789480986000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41591-026-04590-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,17]]},"references-count":71,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["4590"],"URL":"https:\/\/doi.org\/10.1038\/s41591-026-04590-5","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,17]]},"assertion":[{"value":"31 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}